Media Center

Press Inquiries: — 212-417-3638

Browse by Category:

Eyenovia Inc. Prices Public Offering of Common Stock
 National Securities Corporation has acted as the Co-Manager in the Follow-On Offering of Eyenovia, Inc. ORIGINAL PRESS RELEASE RE-POSTED FROM NASDAQ Eyenovia, Inc. Prices Public Offering of Common Stock NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented […]
National Securities Acts as Exclusive Financial Advisor to Interpace Diagnostics in $23.5M Acquisition of BioPharma Business
ORIGINAL PRESS RELEASE BELOW RE-POSTED FROM GLOBENEWSWIRE Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners PARSIPPANY NJ, July 15, 2019 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), announced today that it has acquired assets and certain liabilities constituting the Biopharma Services business […]
Art's Market Commentary
Art Hogan’s Week in Review – July 12, 2019
July 12, 2019 The market saw two round numbers taken out, and all-time highs for the big three indexes. The Dow Jones Industrials took out the 27000 level ending the week at 27332. The S&P 500 found the 3000 milepost this week and was able to close at 3011, up 20% year-to-date. The Nasdaq closed […]